Beauty giant Coty has launched a strategic review of its consumer beauty division, which could see it sell off brands including Rimmel, Max Factor and Sally Hansen. The New York company said it is ...

The New York company said it is reviewing options for its consumer beauty arm as its seeks to focus on its more profitable fragrances operation. Beauty giant Coty has launched a strategic review of ...

Rimmel owner Coty has said it is considering a sale of its consumer beauty brands (Steve Vidler/Alamy/PA) Beauty giant Coty has launched a strategic review of its consumer beauty division, which could ...

Beauty giant Coty has launched a strategic review of its consumer beauty division, which could see it sell off brands including Rimmel, Max Factor and Sally Hansen. The New York company said it is ...

Debutant Max Balard scored just two minutes after coming on to secure the Socceroos a 1-0 win over New Zealand in Canberra on Friday night. The former Central Coast Mariners star, who now plays his ...

House of Beauty aims for significant growth by FY26. Expansion plans include both online and offline strategies. Kylie Cosmetics is set to grow, potentially rivaling Anastasia Beverly Hills. New SKUs ...

You can’t see John Cena, but he saw this coming. On Wednesday, Warner Bros. Discovery announced it was renaming (or is it re-renaming?) its Max streaming service to HBO Max. If the “new” name sounds ...

A rather clever launch from Trinny London, and just in time for summer – Trinity Multitasking Sticks (€44 from Brown Thomas) are a stroke of genius from Trinny Woodall’s beauty brand. There are three ...

Eli Lilly And Co (NYSE:LLY), on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein(a) ...

Eli Lilly (NYSE:LLY) released positive Phase 2 results for its small interfering RNA (siRNA) drug candidate lepodisiran on Sunday. The trial results showed 94% lower levels of a genetically inherited ...

CHICAGO, March 30 (Reuters) - The highest dose of an experimental drug developed by Eli Lilly (LLY.N), opens new tab significantly reduced levels of a genetically inherited risk factor for heart ...